You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
SharePoint
Sign In
Follow
Aligning Health Care Industry Cybersecurity Approaches
At-Risk, Behavioral Health...(ABC)
Redirect to At-Risk webpage on ASPR.HHS.gov
default
Coming in 2022: RISC Toolkit 2.0
Critical Infrastructure Protection
Healthcare and Public Health (HPH) Sector
CIP Inquiry Redirect
Cybersecurity TF
HCIC Task force
Health Care Industry Cybersecurity Task Force Second In-Person Meeting
taskforce-inperson-mtg3
Health Care Industry Cybersecurity Task Force Fourth In-Person Meeting
Health Care Industry Cybersecurity Task Force Overview
Year One Activity Update
EPAP
Health Care Readiness
HPP
Cooperative Agreement Recipient Webinar Materials
HPP Guidance and Reports
HPP in Action
Redirect to HC Near You
Medical Surge Capacity Capability
Medical Surge Capacity Handbook
MSCC Healthcare Coalition
National Emergency Tele Critical Care Network (NETCCN)
National Influenza Vaccine Modernization Strategy 2020-2030
Currently selected
Regional Disaster Health Response System
The Healthcare and Public Health Risk Identification and Site Criticality (RISC) Toolkit
Reference Materials
download
Emergency Operations Plans
White Paper for Zika Vaccine Development Strategy
Site Contents
Skip over global navigation links
Office of the Assistant Secretary for Preparedness and Response
Preparedness
Emergency
About ASPR
Public Health Emergency - Leading a Nation Prepared
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
PHE Home
>
Preparedness
>
Planning
>
National Influenza Vaccine Modernization Strategy 2020-2030
National Influenza Vaccine Modernization Strategy (NIVMS) 2020-2030
Main Content
Right Box1 Content
NIVMS Table of Contents
NIVMS Homepage
Executive Summary
Introduction
Vision and Strategic Objectives
Guiding Principles
Strategic Objectives
Strategic Objective 1: Strengthen and Diversify Influenza Vaccine Development, Manufacturing, and Supply Chain
Strategic Objective 2: Promote Innovative Approaches and Use of New Technologies to Detect, Prevent, and Respond to Influenza
Strategic Objective 3: Increase Influenza Vaccine Access and Coverage Across All Populations
Implementation Approach
Conclusion
Annex A: NIVMS Objectives Crosswalk to EO13887
Right Box2 Content
Printable Version
National Influenza Vaccine Modernization Strategy 2020-2030
This page last reviewed: August 28, 2020
